Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1
Author:
Affiliation:
1. Department of Otolaryngology-Head and Neck Surgery; Shandong Provincial Hospital Affiliated to Shandong University; Jinan China
2. Department of Radiation Oncology; Hangzhou Cancer Hospital; China
Funder
Medical Scientific Development Research Foundation of Shandong Province, China
Publisher
Wiley
Subject
General Biochemistry, Genetics and Molecular Biology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/2211-5463.12135/fullpdf
Reference30 articles.
1. Nasopharyngeal carcinoma;Wei;Lancet,2005
2. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy;Cheng;Int J Radiat Oncol Biol Phys,2000
3. Causes and consequences of microRNA dysregulation in cancer;Croce;Nat Rev Genet,2009
4. A microRNA expression signature of human solid tumors defines cancer gene targets;Volinia;Proc Natl Acad Sci USA,2006
5. miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis;Cheung;Mol Cancer,2014
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The promising role of miRNAs in radioresistance and chemoresistance of nasopharyngeal carcinoma;Frontiers in Oncology;2024-02-28
2. Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect;Journal of Translational Medicine;2023-11-06
3. MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers;Cancer Cell International;2023-08-16
4. miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses;Pathology - Research and Practice;2023-05
5. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway;Immunobiology;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3